Related Experiment Video
Updated: Mar 3, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
CKS1BP7, a Pseudogene of CKS1B, is Co-Amplified with IGF1R in Breast Cancers
Yansong Liu1, Wei Wang2, Yan Li3
1Department of Breast Surgery, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, 250117, People's Republic of China.
Abstract:
Pseudogenes have been reported to exhibit functional roles. Amplification or overexpression of CDC28 protein kinase regulatory subunit 1B (CKS1B) was found in various human cancers. But it was known little about CKS1B pseudogene 7 (CKS1BP7), a pseudogene sharing considerable sequence identity with CKS1B. The aim of this study was to evaluate copy number alterations (CNAs) of CKS1BP7 and address its potential roles in breast cancer. We detected copy numbers of CKS1BP7 and insulin-like growth factor 1 receptor (IGF1R) using quantitative multi-gene fluorescence in situ hybridization (QM-FISH) technique, compared their status in both invasive carcinoma and ductal carcinoma in situ (DCIS) components within the same tumors, and investigated the associations of CNAs with tumor features and patients outcomes. Amplification of CKS1BP7 (dot-like pattern) was found in 28.8% of all cases, while amplified IGF1R (cluster pattern) was identified in 24.2% of all patients. The two events often co-existed (p = 0.01). Within the same tumors, identical CNAs of CKS1BP7 and IGF1R were found in DCIS and invasive carcinoma. Moreover, amplification of both genes was more frequent in aneuploidy tumors and the tumors with high ki67, but wasn't associated with patients' outcome. In summary, CKS1BP7 amplification is a frequent event in breast cancer and often co-occurs with amplified IGF1R, which provides evidence supporting the interactions between CKS1BP7 and IGF1R during mammary carcinogenesis. Our findings suggest that CKS1BP7 as well as IGF1R may serve as potential biomarkers for early detection and predict prognosis in breast cancer.
Insights
Copy number alterations of the CKS1B pseudogene 7 (CKS1BP7) are frequent in breast cancer and often co-occur with amplified insulin-like growth factor 1 receptor (IGF1R). These findings suggest CKS1BP7 and IGF1R roles in mammary carcinogenesis.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Pseudogenes, once considered non-functional, are increasingly recognized for their roles in biological processes.
- Overexpression of CDC28 protein kinase regulatory subunit 1B (CKS1B) is implicated in various human cancers.
- The functional significance of CKS1B pseudogene 7 (CKS1BP7), despite its sequence similarity to CKS1B, remains largely unexplored in breast cancer.
Purpose of the Study:
- To investigate copy number alterations (CNAs) of CKS1BP7 in breast cancer.
- To explore the potential roles of CKS1BP7 in breast cancer development and progression.
- To assess the relationship between CKS1BP7 CNAs, insulin-like growth factor 1 receptor (IGF1R) status, tumor characteristics, and patient outcomes.
Main Methods:
- Quantitative multi-gene fluorescence in situ hybridization (QM-FISH) was employed to detect copy numbers of CKS1BP7 and IGF1R.
- Analysis was performed on both ductal carcinoma in situ (DCIS) and invasive carcinoma components within the same tumor samples.
- Associations between gene CNAs, tumor features (aneuploidy, Ki67 expression), and patient prognosis were examined.
Main Results:
- CKS1BP7 amplification (dot-like pattern) was detected in 28.8% of breast cancer cases.
- IGF1R amplification (cluster pattern) was identified in 24.2% of cases, frequently co-occurring with CKS1BP7 amplification (p=0.01).
- Identical CNAs for CKS1BP7 and IGF1R were observed in both DCIS and invasive components; amplifications were more common in aneuploid tumors with high Ki67 but did not correlate with patient outcomes.
Conclusions:
- CKS1BP7 amplification is a frequent event in breast cancer, often co-occurring with IGF1R amplification, suggesting potential interactions during mammary carcinogenesis.
- The findings support CKS1BP7 and IGF1R as potential biomarkers for early breast cancer detection.
- Both CKS1BP7 and IGF1R may serve as prognostic indicators in breast cancer patients.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

